Skip to main content
. 2023 May 29:1–9. Online ahead of print. doi: 10.1007/s10461-023-04084-2

Table 3.

Primary and secondary outcomes

In-person Telehealth Rate ratio (95% CI)
Time in clinic (PY): 167.4 153.08
Primary Outcomes

 Tablets prescribed per PY (no.)

 Estimated medication possession (%)

 HIV screens per PY (no.)

 Creatinine tests per PY (no.)

324.4

89

3.55

3.51

320.6

88

3.38

3.37

0.99(0.98-1.00)

0.95 (0.85–1.07)

0.96 (0.85–1.08)

Secondary Outcomes

 Syphilis screens per PY (no.)

 CT/GC (urine) screens per PY (no.)

 CT/GC (pharyngeal) screens per PY (no.)

 CT/GC (rectal) screens per PY (no.)

3.11

2.68

0.38

0.36

3.33

3.13

0.94

0.88

1.07 (0.95–1.21)

1.17 (1.03–1.33)

2.46 (1.83–3.30)

2.42 (1.79–3.27)

Loss to Follow-up

 Clinic of most recent PrEP appointment (no.)

 Lost to follow up (no. [%])

40

12 (30)

109

13 (11.9)

Χ [2] (1, N = 149) = 6.85

P = 0.009

PY = Person-Year